Eosinophils increase airway sensory nerve density in mice and in human asthma

Sci Transl Med. 2018 Sep 5;10(457):eaar8477. doi: 10.1126/scitranslmed.aar8477.

Abstract

In asthma, airway nerve dysfunction leads to excessive bronchoconstriction and cough. It is well established that eosinophils alter nerve function and that airway eosinophilia is present in 50 to 60% of asthmatics. However, the effects of eosinophils on airway nerve structure have not been established. We tested whether eosinophils alter airway nerve structure and measured the physiological consequences of those changes. Our results in humans with and without eosinophilic asthma showed that airway innervation and substance P expression were increased in moderate persistent asthmatics compared to mild intermittent asthmatics and healthy subjects. Increased innervation was associated with a lack of bronchodilator responsiveness and increased irritant sensitivity. In a mouse model of eosinophilic airway inflammation, the increase in nerve density and airway hyperresponsiveness were mediated by eosinophils. Our results implicate airway nerve remodeling as a key mechanism for increased irritant sensitivity and exaggerated airway responsiveness in eosinophilic asthma.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Animals
  • Asthma / blood
  • Asthma / complications
  • Asthma / pathology*
  • Asthma / physiopathology
  • Bronchoconstriction / drug effects
  • Bronchodilator Agents / pharmacology
  • Eosinophils / drug effects
  • Eosinophils / pathology*
  • Female
  • Humans
  • Lung / drug effects
  • Lung / innervation*
  • Lung / physiopathology
  • Male
  • Mice, Inbred C57BL
  • Middle Aged
  • Neurons / drug effects
  • Quality of Life
  • Reflex / drug effects
  • Respiratory Hypersensitivity / complications
  • Respiratory Hypersensitivity / pathology
  • Respiratory Hypersensitivity / physiopathology
  • Substance P / metabolism
  • Young Adult

Substances

  • Bronchodilator Agents
  • Substance P